Beam Therapeutics (BEAM) Net Margin Growth (3y) (2022 - 2026)
Powered by 
Analysis
Beam Therapeutics (BEAM) Net Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -5,319.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 31,387.00 |
| 10 | Beam Therapeutics | 3.10 Bn | 3.10 Bn | - | -2.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.46 Mn |
| Mar 31, 2026 | 10,129.00 |
| Dec 31, 2025 | 40,548.00 |
| Sep 30, 2025 | -46,883.00 |
| Jun 30, 2025 | -77,437.00 |
| Mar 31, 2025 | -62,935.00 |
| Dec 31, 2024 | -17,380.00 |
| Sep 30, 2024 | 300,772.00 |
| Jun 30, 2024 | 127.01 Mn |
| Mar 31, 2024 | 335.80 Mn |
| Dec 31, 2023 | 159.11 Mn |
| Sep 30, 2023 | 57.36 Mn |
| Jun 30, 2023 | 56.99 Mn |
| Mar 31, 2023 | 52.85 Mn |
| Dec 31, 2022 | 51.84 Mn |
| Sep 30, 2022 | 37.04 Mn |
| Jun 30, 2022 | 35.10 Mn |